Downey R J, Martini N, Rusch V W, Bains M S, Korst R J, Ginsberg R J
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Ann Thorac Surg. 1999 Jul;68(1):188-93. doi: 10.1016/s0003-4975(99)00456-7.
The long-term survival after operation of patients with lung cancer involving the chest wall is known to be related to regional nodal involvement and completeness of resection, but it is not known whether the depth of chest wall involvement or the type of resection (extrapleural or en bloc) affects either the rate of local recurrence or survival.
We retrospectively reviewed the Memorial Sloan-Kettering Cancer Center experience between 1974 and 1993 of 334 patients undergoing surgical exploration for lung cancer involving the chest wall or parietal pleura.
Of 334 patients who underwent exploration, 175 had apparently complete (R0) resections, 94 had incomplete (R1 or R2) resections, and 65 underwent exploration without resection. The overall 5-year survival of R0 patients was 32%, of R1 or R2 patients 4%, and of patients undergoing exploration without resection 0%. In the patients undergoing R0 resections, the extent of chest wall involvement was limited to the parietal pleura in 80 patients, and extended into the ribs or soft tissues in 95. The 5-year survival of R0 patients with T3 N0 M0 disease was 49%, T3 N1 M0 disease 27%, and T3 N2 M0 disease 15% (p < 0.0003). Independent of lymph node involvement, a survival advantage was observed in R0 patients if the chest wall involvement was limited to parietal pleura only, rather than invading into the chest wall musculature or ribs.
Survival of patients with lung cancer invading the chest wall after resection with curative intent is highly dependent on the extent of nodal involvement and the completeness of resection, and much less so on the depth of chest wall invasion.
已知侵犯胸壁的肺癌患者术后长期生存与区域淋巴结受累及切除的完整性有关,但胸壁受累深度或切除类型(胸膜外或整块切除)是否影响局部复发率或生存率尚不清楚。
我们回顾性分析了纪念斯隆凯特琳癌症中心1974年至1993年间334例因侵犯胸壁或壁层胸膜的肺癌而接受手术探查的患者的资料。
在334例接受探查的患者中,175例实现了明显完整(R0)切除,94例为不完整(R1或R2)切除,65例仅接受了探查而未进行切除。R0患者的总体5年生存率为32%,R1或R2患者为4%,仅接受探查未切除的患者为0%。在接受R0切除的患者中,80例胸壁受累范围仅限于壁层胸膜,95例扩展至肋骨或软组织。T3 N0 M0疾病的R0患者5年生存率为49%,T3 N1 M0疾病为27%,T3 N2 M0疾病为15%(p<0.0003)。与淋巴结受累无关,若胸壁受累仅限于壁层胸膜而非侵犯胸壁肌肉组织或肋骨,R0患者可观察到生存优势。
根治性切除术后侵犯胸壁的肺癌患者的生存高度依赖于淋巴结受累程度和切除的完整性,而较少依赖于胸壁侵犯深度。